Clinical studies have shown that patients may lose an average of 15-20% of their starting body weight over the course of treatment, but this depends on adherence to medication, diet, and exercise recommendations
About DrFirst Since 2000, healthcare IT pioneer DrFirst has empowered providers and patients to achieve better health through intelligent medication management
References Tirzepatide Microdose (Compounded) Tirzepatide Microdose is a lower-strength compounded formulation of the same dual GLP-1/GIP receptor agonist, designed for patients who prefer a gradual introduction to dual-action therapy or who have experienced side effects at higher doses
For many patients, headaches diminish or resolve completely as treatment continues and the body adjusts to the medication
Those interested in starting semaglutide for blood sugar control or weight loss should consult their physician to determine if the medication is right for them
[52] This increases the drug's binding to blood protein (albumin), which enables longer presence in the blood circulation